PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Aug-2022 Evolva with record half-yearly sales and new mid-term plan Evolva Holding SA
24-Aug-2022 AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022 AEVIS VICTORIA SA
24-Aug-2022 Cellefill™, a new integrated solution to fast-track cell, gene and biological therapies Sciad Newswire
24-Aug-2022 AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022 AEVIS VICTORIA SA
24-Aug-2022 Relief Therapeutics files registration statement on form F-1 with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
23-Aug-2022 Bristol Myers Squibb UK&I is first pharmaceutical company to be accredited as a Menopause Friendly Workplace Bristol Myers Squibb UK&I
23-Aug-2022 European Medicines Agency commences review of oral fixed-dose combination of decitabine and cedazuridine for the treatment of adults with acute myeloid leukaemia Otsuka Pharmaceutical Europe Ltd
23-Aug-2022 Kinarus Therapeutics to hold webinar on a new approach to treating COVID-19 Kinarus Therapeutics
23-Aug-2022 Dermapharm Holding SE: Successful first half of 2022 in challenging market environment Dermapharm Holding SE
23-Aug-2022 Douglas GmbH: DOUGLAS continues to accelerate growth in the third quarter - significant increase in sales and earnings Douglas GmbH
23-Aug-2022 SKAN Group with strong order growth in the first half of 2022 SKAN AG
23-Aug-2022 Kuros Biosciences’ MagnetOs Bone Graft Successfully Achieves Three Key Milestones Kuros Biosciences AG
23-Aug-2022 Evolva statement to SER communication Evolva Holding SA
22-Aug-2022 Kinarus Therapeutics to hold webinar on a new approach to treating COVID-19 Kinarus Therapeutics Holding AG
22-Aug-2022 Kinarus announces the issuance of convertible notes of up to CHF 20 million to an entity managed by Yorkville Kinarus Therapeutics Holding AG
22-Aug-2022 Intron Health initiates research coverage of Xlife Sciences Xlife Sciences AG
22-Aug-2022 Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. announce tentative settlement of pending litigation Relief Therapeutics Holding SA
19-Aug-2022 Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius Fresenius SE & Co. KGaA
19-Aug-2022 European Commission approves Celltrion Healthcare’s Vegzelma™ (CT-P16, biosimilar bevacizumab) for the treatment of multiple types of cancer Celltrion Healthcare
19-Aug-2022 Weekly Pharma & Life Science News Round-Up: 15th – 19th August PharmiWeb.Jobs